273 related articles for article (PubMed ID: 35005863)
1. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
4. Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review.
Lapidus AH; Lee S; Liu ZF; Smithson S; Chew CY; Gin D
J Cutan Med Surg; 2024 May; ():12034754241256347. PubMed ID: 38783539
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR; Tabacchi M; Ngo KH; Wallendorf M; Rosman IS; Cornelius LA; Demehri S
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895944
[TBL] [Abstract][Full Text] [Related]
6. Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
Miller AC; Adjei S; Temiz LA; Tyring SK
Skin Therapy Lett; 2022 Jul; 27(4):4-7. PubMed ID: 35857917
[TBL] [Abstract][Full Text] [Related]
7. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
[TBL] [Abstract][Full Text] [Related]
8. Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
Kempers S; DuBois J; Forman S; Poon A; Cutler E; Wang H; Cutler D; Fang J; Kwan R
J Drugs Dermatol; 2020 Nov; 19(11):1093-1100. PubMed ID: 33196758
[TBL] [Abstract][Full Text] [Related]
9. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
[TBL] [Abstract][Full Text] [Related]
10. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
11. INDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials.
Rajkumar JR; Armstrong AW; Kircik LH
J Drugs Dermatol; 2021 Oct; 20(10):s4s4-s14. PubMed ID: 34636523
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
13. 1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.
Dao DD; Sahni VN; Sahni DR; Balogh EA; Grada A; Feldman SR
Ann Pharmacother; 2022 Apr; 56(4):494-500. PubMed ID: 34301153
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis.
Heppt MV; Steeb T; Leiter U; Berking C
J Eur Acad Dermatol Venereol; 2019 May; 33(5):863-873. PubMed ID: 30710390
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Arcuri D; Ramchatesingh B; Lagacé F; Iannattone L; Netchiporouk E; Lefrançois P; Litvinov IV
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902419
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
17. Treatment of actinic keratosis: a systematic review.
Worley B; Harikumar V; Reynolds K; Dirr MA; Christensen RE; Anvery N; Yi MD; Poon E; Alam M
Arch Dermatol Res; 2023 Jul; 315(5):1099-1108. PubMed ID: 36454335
[TBL] [Abstract][Full Text] [Related]
18. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study of microwave therapy for precancerous actinic keratosis.
Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
Tanghetti E; Werschler P
J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]